COSCIENS Biopharma (CSCI) Return On Assets

Annual ROA

-13.79%
-26.22%-210.94%

December 1, 2023


Summary


Performance

CSCI ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIprofitabilitymetrics:

Quarterly ROA

-31.07%
-13.23%-74.16%

September 1, 2024


Summary


Performance

CSCI Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

CSCI ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-210.9%-126.8%
3 y3 years-307.4%-126.8%
5 y5 years-1109.7%-126.8%

CSCI ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-210.9%at low-271.9%at low
5 y5-year-210.9%at low-271.9%at low
alltimeall time-127.9%+95.5%-136.6%+91.8%

COSCIENS Biopharma ROA History

DateAnnualQuarterly
Sep 2024
-
-31.07%(+74.2%)
Jun 2024
-
-17.84%(-5.5%)
Mar 2024
-
-18.88%(+37.8%)
Dec 2023
-13.79%(-210.9%)
-13.70%(+75.2%)
Sep 2023
-
-7.82%(+281.5%)
Jun 2023
-
-2.05%(-132.1%)
Mar 2023
-
6.38%(-51.4%)
Dec 2022
12.43%(+11.3%)
13.12%(-27.2%)
Sep 2022
-
18.01%(-0.3%)
Jun 2022
-
18.07%(+19.5%)
Mar 2022
-
15.12%(+35.7%)
Dec 2021
11.17%(+68.0%)
11.14%(+99.3%)
Sep 2021
-
5.59%(+66.4%)
Jun 2021
-
3.36%(-27.3%)
Mar 2021
-
4.62%(-29.4%)
Dec 2020
6.65%(-251.5%)
6.54%(-25.9%)
Sep 2020
-
8.82%(+12.6%)
Jun 2020
-
7.83%(+299.5%)
Mar 2020
-
1.96%(-146.1%)
Dec 2019
-4.39%(+285.1%)
-4.25%(+37.5%)
Sep 2019
-
-3.09%(-19.7%)
Jun 2019
-
-3.85%(+63.1%)
Mar 2019
-
-2.36%(+110.7%)
Dec 2018
-1.14%(-68.8%)
-1.12%(-87.5%)
Sep 2018
-
-8.96%(+33.9%)
Jun 2018
-
-6.69%(+39.4%)
Mar 2018
-
-4.80%(+29.4%)
Dec 2017
-3.65%(-121.0%)
-3.71%(-233.0%)
Sep 2017
-
2.79%(-36.4%)
Jun 2017
-
4.39%(-58.2%)
Mar 2017
-
10.51%(-40.6%)
Dec 2016
17.40%(-56.0%)
17.68%(-54.9%)
Sep 2016
-
39.20%(-22.5%)
Jun 2016
-
50.58%(+0.9%)
Mar 2016
-
50.14%(+13.1%)
Dec 2015
39.55%(+64.2%)
44.33%(+171.5%)
Sep 2015
-
16.33%(+8.3%)
Jun 2015
-
15.08%(-12.6%)
Mar 2015
-
17.25%(-26.8%)
Dec 2014
24.08%(+533.7%)
23.56%(-2.1%)
Sep 2014
-
24.06%(+45.6%)
Jun 2014
-
16.53%(-1107.9%)
Mar 2014
-
-1.64%(-134.9%)
Dec 2013
3.80%(-128.1%)
4.70%(+273.0%)
Sep 2013
-
1.26%(-122.0%)
Jun 2013
-
-5.73%(+70.5%)
Mar 2013
-
-3.36%(-74.8%)
Dec 2012
-13.54%(-182.6%)
-13.34%(+958.7%)
Sep 2012
-
-1.26%(+240.5%)
Jun 2012
-
-0.37%(-105.2%)
Mar 2012
-
7.09%(-61.2%)
Dec 2011
16.39%(-3.4%)
18.27%(+4.3%)
Sep 2011
-
17.52%(-29.5%)
Jun 2011
-
24.84%(-16.7%)
Mar 2011
-
29.81%(+76.7%)
Dec 2010
16.97%
16.87%(-246.2%)
DateAnnualQuarterly
Sep 2010
-
-11.54%(-23.2%)
Jun 2010
-
-15.02%(+72.2%)
Mar 2010
-
-8.72%(+108.6%)
Dec 2009
-2.48%(-96.9%)
-4.18%(-71.1%)
Sep 2009
-
-14.44%(-50.4%)
Jun 2009
-
-29.10%(-59.7%)
Mar 2009
-
-72.27%(-12.3%)
Dec 2008
-80.66%(+84.0%)
-82.43%(+24.6%)
Sep 2008
-
-66.16%(+3.4%)
Jun 2008
-
-64.01%(+32.6%)
Mar 2008
-
-48.27%(+25.3%)
Dec 2007
-43.83%(+261.3%)
-38.53%(+22.9%)
Sep 2007
-
-31.34%(+89.6%)
Jun 2007
-
-16.53%(+60.8%)
Mar 2007
-
-10.28%(-10.5%)
Dec 2006
-12.13%(+333.2%)
-11.49%(+692.4%)
Sep 2006
-
-1.45%(-44.7%)
Jun 2006
-
-2.62%(-221.3%)
Mar 2006
-
2.16%(-170.1%)
Dec 2005
-2.80%(-89.9%)
-3.08%(-82.0%)
Sep 2005
-
-17.14%(-44.7%)
Jun 2005
-
-30.97%(-31.0%)
Mar 2005
-
-44.89%(+49.5%)
Dec 2004
-27.61%(-155.8%)
-30.02%(-13.8%)
Sep 2004
-
-34.82%(-268.9%)
Jun 2004
-
20.61%(-60.2%)
Mar 2004
-
51.76%(+2.8%)
Dec 2003
49.48%(+116.8%)
50.36%(-40.7%)
Sep 2003
-
84.97%(+38.5%)
Jun 2003
-
61.37%(+34.4%)
Mar 2003
-
45.65%(+99.9%)
Dec 2002
22.82%(-122.6%)
22.84%(-52.1%)
Sep 2002
-
47.64%(+628.4%)
Jun 2002
-
6.54%(-108.0%)
Mar 2002
-
-81.59%(-6.8%)
Dec 2001
-100.96%(-67.2%)
-87.52%(-60.6%)
Sep 2001
-
-221.86%(+5.2%)
Jun 2001
-
-210.81%(+7.4%)
Mar 2001
-
-196.21%(-12.7%)
Dec 2000
-307.46%(+30.2%)
-224.72%(-8.4%)
Sep 2000
-
-245.43%(-3.3%)
Jun 2000
-
-253.70%(+14.1%)
Mar 2000
-
-222.27%(+15.1%)
Dec 1999
-236.23%(+20.5%)
-193.13%(-48.8%)
Sep 1999
-
-377.28%(+18.6%)
Jun 1999
-
-318.13%(+61.2%)
Mar 1999
-
-197.40%(+34.8%)
Dec 1998
-196.08%(+61.0%)
-146.44%(+13.8%)
Sep 1998
-
-128.66%(+79.0%)
Jun 1998
-
-71.86%(+15.8%)
Mar 1998
-
-62.04%(+4.2%)
Dec 1997
-121.76%(+512.2%)
-59.56%(+274.4%)
Sep 1997
-
-15.91%(+56.0%)
Jun 1997
-
-10.20%(+131.3%)
Mar 1997
-
-4.41%
Dec 1996
-19.89%
-

FAQ

  • What is COSCIENS Biopharma annual return on assets?
  • What is the all time high annual ROA for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual ROA year-on-year change?
  • What is COSCIENS Biopharma quarterly return on assets?
  • What is the all time high quarterly ROA for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly ROA year-on-year change?

What is COSCIENS Biopharma annual return on assets?

The current annual ROA of CSCI is -13.79%

What is the all time high annual ROA for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual return on assets is 49.48%

What is COSCIENS Biopharma annual ROA year-on-year change?

Over the past year, CSCI annual return on assets has changed by -26.22% (-210.94%)

What is COSCIENS Biopharma quarterly return on assets?

The current quarterly ROA of CSCI is -31.07%

What is the all time high quarterly ROA for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly return on assets is 84.97%

What is COSCIENS Biopharma quarterly ROA year-on-year change?

Over the past year, CSCI quarterly return on assets has changed by -17.37% (-126.79%)